In the presentation by RVX on Nov 18th they talk applying for BTD,   but i am not for if they use the plural because they applying to both the FDA & EMA or because they are applying for BTD for more than 1 indication,.... anyone,...?

In the near term we will continue our five point approach to progressing our corporate commercial value. This approach involves aggressive exploratory development of the following • • • • •

Breakthrough Therapy status filings, both FDA and EMA, over the next 90/120 days

SGLT2i partnering discussions, one has already been initiated, key patent already filed

Renal partnering discussions ASAP Congestive Heart Failure partnering discussions ASAP, already initiated

Orphan partnering discussions initially focused on PAH and HIV only at this time.

PAH enrollment has already commenced. HIV funding being derived from a yet to be named US based organization